Lee; Hee Gu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lee; Hee Gu.The latest application filed is for "method for treating allergic skin disease or pruritus cutaneous".

Company Profile

1.14.16

Lee; Hee Gu - Daejeon KR
Lee; Hee Gu - Dong-gu KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-inflammatory composition comprising acylhydrazone derivative Grant 11,446,281 - Kim , et al. September 20, 2	2022-09-20
Method For Treating Allergic Skin Disease Or Pruritus Cutaneous App 20220151959 - KIM; Bo Yeon ; et al.	2022-05-19
Anti-inflammatory Composition Comprising Acylhydrazone Derivative App 20210030716 - KIM; Bo Yeon ; et al.	2021-02-04
Pharmaceutical composition for treating cancer Grant 9,217,149 - Won , et al. December 22, 2	2015-12-22
CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer Grant 9,075,066 - Lee , et al. July 7, 2	2015-07-07
Pharmaceutical composition for treating wounds or revitalizing skin comprising Euphorbia kansui extracts, fractions thereof or diterpene compounds separated from the fractions as active ingredient Grant 9,061,022 - Kim , et al. June 23, 2	2015-06-23
G protein coupled receptor protein and use thereof Grant 9,034,327 - Chung , et al. May 19, 2	2015-05-19
Pharmaceutical Composition For Treating Wounds Or Revitalizing Skin Comprising Euphorbia Kansui Extracts, Fractions Thereof Or Diterpene Compounds Separated From The Fractions As Active Ingredient App 20150093456 - KIM; Jae Wha ; et al.	2015-04-02
Pharmaceutical Composition For Treating Cancer App 20140371300 - Won; Misun ; et al.	2014-12-18
Pharmaceutical composition for treating cancer Grant 8,846,630 - Won , et al. September 30, 2	2014-09-30
Use of FLJ25416 gene Grant 8,486,905 - Won , et al. July 16, 2	2013-07-16
Pharmaceutical Composition For Treating Cancer App 20130028957 - Won; Misun ; et al.	2013-01-31
Characterization of ESM-1 as a tumor associated marker of colorectal cancer Grant 8,283,129 - Song , et al. October 9, 2	2012-10-09
Novel Biomarker For Liver Cancer And Applications For Same App 20110306513 - Song; Eun Young ; et al.	2011-12-15
Diagnostic Kit Of Colon Cancer Using Colon Cancer Related Marker And Diagnostic Method Thereof App 20110251097 - Song; Eun Young ; et al.	2011-10-13
Biomarkers Indicative of Colon Cancer and Metastasis and Diagnosis and Screening Therapeutics Using the Same App 20110201512 - Lee; Hee Gu ; et al.	2011-08-18
Cst1, Dcc1, Ifitm1 Or Melk As Markers For Diagnosing Stomach Cancer App 20110152106 - Lee; Hee Gu ; et al.	2011-06-23
Novel Use Of Flj25416 Gene App 20110008370 - Won; Misun ; et al.	2011-01-13
Characterization of ESM-1 as a Tumor Associated Marker of Colorectal Cancer App 20100248244 - Song; Eun Young ; et al.	2010-09-30
Ppia Marker For Diagnosis Of Liver Cancer And Antibody, And Screening Method Of Compounds Useful For Inhibiting Liver Cancer App 20100203510 - Kim; Dae-Ghon ; et al.	2010-08-12
Preparation of monoclonal antibody to N-myc downstream regulated gene 2 and determination of NDRG2 using protein chip Grant 7,718,780 - Song , et al. May 18, 2	2010-05-18
IL-32 monoclonal antibodies and uses thereof Grant 7,641,904 - Kim , et al. January 5, 2	2010-01-05
MAC-2BP as a Marker for the Diagnosis of Gastric Cancer App 20090130694 - Lee; Hee Gu ; et al.	2009-05-21
Il-32 Monoclonal Antibodies And Uses Thereof App 20080219995 - Kim; Ki-Hong ; et al.	2008-09-11
Preparation of monoclonal antibody to N-myc downstream regulated gene 2 and determination of NDRG2 using protein chip App 20070128194 - Song; Eun Young ; et al.	2007-06-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.